文献速递睡眠呼吸障碍咽喉与嗓音

上气道刺激术前后或未行悬雍垂腭咽成形术的两年疗效观察

Upper-Airway Stimulation Before, After, or Without Uvulopalatopharyngoplasty: A Two-Year Perspective.
PubMed 文献 · Laryngoscope · 2018-09-24

本研究纳入全部连续接受上气道刺激(UAS)植入且完成1年和2年随访评估的患者,比较UAS后(组1)、UAS前(组2)及未行(组3)悬雍垂腭咽成形术联合扁桃体切除术(UPPP-TE)的疗效。结果显示全队列约80%治疗成功,组2与组3在肥胖、呼吸暂停低通气指数或氧减指数上无显著差异,组1初始睡眠内镜下腭部及口咽部无阻塞者更少、口咽侧壁阻塞模式更常见。结论认为UAS植入后持续OSA若阻塞位于腭垂和口咽水平应考虑UPPP-TE,但不推荐UAS植入前常规行UPPP-TE。

要点

  • UAS植入后持续OSA且阻塞在腭垂和口咽水平者,可考虑行UPPP-TE。
  • 不推荐患者在UAS植入前常规接受UPPP-TE。
  • 全队列约80%患者获得治疗成功。

核心结论

  • UAS植入后持续OSA若阻塞位于腭垂和口咽水平,应考虑UPPP-TE。
  • UAS患者行UPPP-TE可获得更高应答率和更好结局,但无指征在UAS植入前常规行UPPP-TE。

研究设计与样本

  • 研究纳入全部连续接受UAS植入且完成1年和2年随访评估(M12和M24)的患者。
  • 病例分为三组:UAS后行UPPP-TE(组1)、UAS前行UPPP-TE(组2)和未行UPPP-TE(组3)。
  • 证据等级为4级,发表于Laryngoscope 2019;129:514-518。

主要发现

  • 全队列约80%患者获得治疗成功。
  • 组2与组3在肥胖、呼吸暂停低通气指数或氧减指数方面无显著差异。
  • 初始睡眠内镜下,组1相比组2和组3,腭部及口咽部无任何阻塞的患者更少,口咽侧壁阻塞模式更常见。
  • 组2与组3结果相似,尽管组2患者在UAS植入前接受了UPPP-TE。

临床怎么用

  • UAS植入后持续OSA且阻塞定位在腭垂和口咽水平者,可考虑行UPPP-TE以改善应答。
  • 不应在UAS植入前常规行UPPP-TE。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Upper airway stimulation (UAS) is an effective second-line treatment for obstructive sleep apnea (OSA). In certain patients, there is a considerable need for advanced programming, notably with inadequate palatal response to therapy. The aim of the study was to investigate the impact of uvulopalatopharyngoplasty and tonsillectomy (UPPP-TE) on UAS therapy outcomes from a 2-year perspective after implantation. METHODS: This study included all consecutive patients implanted with UAS in which a full set of 1- and 2-year follow-up assessments (M12 and M24) were obtained. Cases were analyzed in three groups: patients with UPPP-TE after (group 1) and before (group 2) UAS, and those without UPPP-TE (group 3). RESULTS: Therapy success could be achieved in about 80% of the entire cohort. Groups 2 and 3 did not differ significantly with regard to obesity, Apnea-Hypopnea Index, or Oxygen Desaturation Index. With regard to initial sleep endoscopy, there were fewer patients without any obstruction at the palatal and oropharyngeal levels and higher prevalence of lateral obstruction patterns at oropharynx in group 1 in contrast to groups 2 and 3. Groups 2 and 3 showed similar results, although group 2 patients underwent UPPP-TE before UAS implantation. CONCLUSION: UPPP-TE should be considered in patients with persistent OSA after UAS implantation if the obstruction is identified at the level of velum and oropharynx. Although this approach has higher response rates and better outcomes can be achieved in patients with UAS, there is no indication for patients to routinely undergo UPPP-TE prior to UAS implantation. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:514-518, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Steffen A, Abrams N, Suurna MV, et al. Upper-Airway Stimulation Before, After, or Without Uvulopalatopharyngoplasty: A Two-Year Perspective. Laryngoscope. 2018. PMID: 30247759. doi:10.1002/lary.27357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。